With over 700,000 patients treated, AtriClip is the global leader in LAAE. Explore our portfolio, offering both open and minimally invasive options to suit your practice and patients: <a href="https://t.co/FEOb4mDkoG&quot; target="_blank">https://t.co/FEOb4mDkoG</a&gt; ​

<a href="https://twitter.com/hashtag/AtriClip?src=hashtag_click&quot; target="_blank">#AtriClip</a> <a href="https://twitter.com/hashtag/LAAE?src=hashtag_click&quot; target="_blank">#LAAE</a> <a href="https://twitter.com/hashtag/CardioTwitter?src=hashtag_click&quot; target="_blank">#CardioTwitter</a>

With over 700,000 patients treated, AtriClip is the global leader in LAAE. Explore our portfolio, offering both open and minimally invasive options to suit your practice and patients: <a href="https://okt.to/XuSGRA&quot; target="_blank">https://okt.to/XuSGRA</a&gt; ​

<a href='https://www.linkedin.com/feed/hashtag/?keywords=AtriClip&highlightedUpd…; target='_blank'>#AtriClip</a> <a href='https://www.linkedin.com/feed/hashtag/?keywords=LAAE&highlightedUpdateU…; target='_blank'>#LAAE</a> <a href='https://www.linkedin.com/feed/hashtag/?keywords=CardiacSurgery&highligh…; target='_blank'>#CardiacSurgery</a>

AtriCure is pleased to announce the first patients have been treated with our novel dual energy platform that integrates PFA with Advanced RFA. The new platform delivers the benefits of both technologies while decreasing ablation time, building on our innovative EnCompass clamp Isolator® Synergy™ ablation system. This device is available for investigational use only.

Learn more about the latest innovation here: <a href="https://okt.to/b8dUsu&quot; target="_blank">https://okt.to/b8dUsu</a&gt;

Nearly 45% of lower-extremity amputees continue opioid use a year after surgery. Cryo Nerve Block offers an innovative, non-opioid approach as part of a multimodal pain management strategy to manage pain right at the time of the procedure.​

Discover how: <a href="https://t.co/AgXH1SYKU0&quot; target="_blank">https://t.co/AgXH1SYKU0</a&gt;

AtriCure is pleased to announce the first patients have been treated with our novel dual energy platform that integrates PFA with Advanced RFA. The new platform delivers the benefits of both technologies; building on our innovative EnCompass clamp technology. This device is

Nearly 45% of lower-extremity amputees continue opioid use a year after surgery. Cryo Nerve Block offers an innovative, non-opioid approach as part of a multimodal pain management strategy to manage pain right at the time of the procedure.​

Discover how: <a href="https://okt.to/zQ7Kft&quot; target="_blank">https://okt.to/zQ7Kft</a&gt; ​

<a href='https://www.linkedin.com/feed/hashtag/?keywords=PainManagement&highligh…; target='_blank'>#PainManagement</a> <a href='https://www.linkedin.com/feed/hashtag/?keywords=Amputation&highlightedU…; target='_blank'>#Amputation</a> <a href='https://www.linkedin.com/feed/hashtag/?keywords=VascSurg&highlightedUpd…; target='_blank'>#VascSurg</a>

Great weekend at <a href="https://twitter.com/hashtag/ICC2025?src=hashtag_click&quot; target="_blank">#ICC2025</a>! Alongside surgeons and physicians, we explored how treating Afib during CABG addresses two challenges at once while improving patient survivability*. These discussions are helping advance a shared understanding of comprehensive patient care.

Great weekend at <a href='https://www.linkedin.com/feed/hashtag/?keywords=ICC2025&highlightedUpda…; target='_blank'>#ICC2025</a>! Alongside surgeons and physicians, we explored how treating Afib during CABG addresses two challenges at once while improving patient survivability*. These discussions are helping advance a shared understanding of comprehensive patient care. Thanks to those who joined us!

Reference: <a href="https://okt.to/mGkQ4P&quot; target="_blank">https://okt.to/mGkQ4P</a&gt;
<a href='https://www.linkedin.com/feed/hashtag/?keywords=Afib&highlightedUpdateU…; target='_blank'>#Afib</a> <a href='https://www.linkedin.com/feed/hashtag/?keywords=CABG&highlightedUpdateU…; target='_blank'>#CABG</a>

Surgeons know adaptability matters.​​
The EnCompass® clamp is available in two sizes —standard and long, giving surgeons the flexibility to match diverse patient anatomy. ​​

Adopt the right tool for the patient. EnCompass: <a href="https://t.co/Kby7O0yazG&quot; target="_blank">https://t.co/Kby7O0yazG</a&gt; ​

<a href="https://twitter.com/hashtag/Ablation?src=hashtag_click&quot; target="_blank">#Ablation</a> <a href="https://twitter.com/hashtag/CardioTwitter?src=hashtag_click&quot; target="_blank">#CardioTwitter</a>

Surgeons know adaptability matters.​​

The EnCompass® clamp is available in two sizes —standard and long, giving surgeons the flexibility to match diverse patient anatomy. ​​

Adopt the right tool for the patient. Learn more about EnCompass at: <a href="https://okt.to/n4lZ9W&quot; target="_blank">https://okt.to/n4lZ9W</a&gt; ​

<a href='https://www.linkedin.com/feed/hashtag/?keywords=Ablation&highlightedUpd…; target='_blank'>#Ablation</a> <a href='https://www.linkedin.com/feed/hashtag/?keywords=CardiacSurgery&highligh…; target='_blank'>#CardiacSurgery</a>